INmune Bio (INMB) shares fell 7.4% in recent Tuesday trading after BTIG Research downgraded the stock to neutral from buy.
Trading volume stood at over 7.5 million shares compared with a daily average of about 2 million.
Price: 2.14, Change: -0.17, Percent Change: -7.36